-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IihXmotTmsXsWtHmFcaOUIkQyFHV1eKAjqv/SvrsIWCKWwObQF0xWvKtzTFwMTef qrhvlTkAgCd+jGfo1r6w5Q== 0001144204-07-050831.txt : 20071109 0001144204-07-050831.hdr.sgml : 20071109 20070924154741 ACCESSION NUMBER: 0001144204-07-050831 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070924 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SKYSTAR BIO-PHARMACEUTICAL CO CENTRAL INDEX KEY: 0001076939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330901534 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: RM 10601, JIEZUO PLAZA, NO. 4 STREET 2: FENGHUI ROAD SOUTH, GAOXIN DISTRICT CITY: XIAN PROVINCE STATE: F4 ZIP: 00000 BUSINESS PHONE: 407-645-4433 MAIL ADDRESS: STREET 1: RM 10601, JIEZUO PLAZA, NO. 4 STREET 2: FENGHUI ROAD SOUTH, GAOXIN DISTRICT CITY: XIAN PROVINCE STATE: F4 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: CYBER GROUP NETWORK CORP DATE OF NAME CHANGE: 20000711 CORRESP 1 filename1.htm Unassociated Document
SKYSTAR BIO-PHARMACEUTICAL COMPANY
Room 10601, Jiezuo Plaza, No. 4
Fenghui Road South, Gaoxin District
Xian Province, People’s Republic of China

September 24, 2007  

Filed as Correspondence via EDGAR

Securities and Exchange Commission
450 Fifth Street, N. W.
Washington, D.C. 20549

Re:
Skystar Bio-Pharmaceutical Company
 
Registration Statement - Form SB-2 (Registration No. 333-143449)

Ladies and Gentlemen:

Skystar Bio-Pharmaceutical Company (the “Company”) hereby requests that the Commission take appropriate action to cause the above-referenced registration statement on Form SB-2 to become effective on September 25, 2007 at 9:00 a.m. Washington, D.C. time.

The Company hereby acknowledges the following:

·     
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
 
·     
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
 
·     
the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
 
 
 
 Very truly yours,
     
  SKYSTAR BIO-PHARMACEUTICAL COMPANY
     
  By:
/s/ Scott Cramer                    
   
Scott Cramer
   
Director

 
 -----END PRIVACY-ENHANCED MESSAGE-----